Pharmacokinetics of propranolol and sotalol in hyperthyroidism
β Scribed by A. Aro; M. Anttila; T. Korhonen; H. Sundquist
- Publisher
- Springer
- Year
- 1982
- Tongue
- English
- Weight
- 621 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The pharmacokinetics of d-sotalol has been studied in six healthy volunteers given single doses of 0.25, 0.50, 1, 2 mg.kg-1 i.v. and one 100 mg oral dose in comparison with the kinetics of 1 mg.kg-1 i.v. of dl-sotalol. There was no significant difference in the disposition of the d-enantiomer and th
In a dose of 40 mg, sotalol (MJ 1999) was more potent than 10 mg propranolol in blocking the cardiovascular effects of isoproterenol (5 healthy males, age 22--28 years). In a dose of 10 mg sotalol had weaker blocking properties. In a dose of 10 mg, propranolol under true basal conditions significant
## Abstract We describe a thyrotoxic patient with choreic movements. The latter gradually receded and disappeared as the patient was treated with methimazole and Ξ²βadrenoceptor blocker, and the improvement deteriorated during a Ξ²βadrenoceptor challenge test. Our findings suggest that the pathogenes
## Summary The perioperative course of 44 hyperthyroid patients prepared for surgery with propranolol alone, including 11 with severe thyrotoxicosis was compared to that of 20 euthyroid patients prepared for surgery with carbimazole. Conventional propranolol at a dosage of 160 mg/day was frequently